Kirby McInerney LLP Announces Investigation Against Nutex Health Inc. on Behalf of Investors

Core Viewpoint - Nutex Health Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, following a significant surge in its share price and subsequent allegations of fraudulent activities related to its revenue reporting [1][3]. Group 1: Share Price Surge and Allegations - On July 22, 2025, Blue Orca Capital published a report claiming that Nutex's recent 20-fold share price increase was artificially inflated by a third-party vendor, HaloMD, which allegedly facilitated inflated billing awards [3]. - The report indicated that multiple federal lawsuits have been filed against HaloMD, alleging a fraudulent scheme that siphoned millions from insurers, raising doubts about the legitimacy of Nutex's reported revenue [3]. - Following the report, Nutex's share price fell by $11.18, approximately 10.05%, from $111.19 on July 21, 2025, to $100.01 on July 22, 2025 [3]. Group 2: Delay in Financial Reporting - On August 14, 2025, Nutex announced a delay in filing its quarterly financial statements for the period ending June 30, 2025, due to incomplete accounting adjustments [4]. - This announcement led to a further decline in Nutex's share price by $18.22, or approximately 16.39%, from $111.13 on August 14, 2025, to close at $92.91 on August 15, 2025 [4].